Xia-Qing Gao1, Yan-Fang Li2, Zhi-Li Jiang1. 1. Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, China; Beijing Institute of Heart Lung and Blood Vessel Diseases, China. 2. Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, China; Beijing Institute of Heart Lung and Blood Vessel Diseases, China. Electronic address: liyf101@sohu.com.
Abstract
BACKGROUND: Statins may be beneficial in treating acute lung injury (ALI) or acute respiratory distress syndrome (ARDS), but their application remains controversial. OBJECTIVES: This meta-analysis of published studies investigated their potential benefit in ALI/ARDS treatment. METHODS: PubMed, EMBASE, Google Scholar and Cochrane databases were searched and all randomized controlled trials (RCT) and cohort studies with head-to-head comparison between statin and standard care were included. RESULTS: Three RCTs and six cohort studies were included. Overall, statins treatment had no significant effect on mortality compared with placebo (RCTs: OR = 0.99, 95% CI = 0.72, 1.37; cohorts: OR = 0.99, 95% CI = 0.71, 1.37). In addition, ventilator-free days were comparable between the two groups (RCTs: SMD = 0.08, 95% CI = -0.03, 0.19; cohorts: SMD = 0.06, 95% CI = -0.17, 0.29). The one-way sensitivity analysis confirmed the stability of results. CONCLUSION: The results did not show that statins had effects on mortality and ventilator-free days among ALI/ARDS patients. However, this meta-analysis is limited by the number of RCTs included.
BACKGROUND: Statins may be beneficial in treating acute lung injury (ALI) or acute respiratory distress syndrome (ARDS), but their application remains controversial. OBJECTIVES: This meta-analysis of published studies investigated their potential benefit in ALI/ARDS treatment. METHODS: PubMed, EMBASE, Google Scholar and Cochrane databases were searched and all randomized controlled trials (RCT) and cohort studies with head-to-head comparison between statin and standard care were included. RESULTS: Three RCTs and six cohort studies were included. Overall, statins treatment had no significant effect on mortality compared with placebo (RCTs: OR = 0.99, 95% CI = 0.72, 1.37; cohorts: OR = 0.99, 95% CI = 0.71, 1.37). In addition, ventilator-free days were comparable between the two groups (RCTs: SMD = 0.08, 95% CI = -0.03, 0.19; cohorts: SMD = 0.06, 95% CI = -0.17, 0.29). The one-way sensitivity analysis confirmed the stability of results. CONCLUSION: The results did not show that statins had effects on mortality and ventilator-free days among ALI/ARDSpatients. However, this meta-analysis is limited by the number of RCTs included.
Authors: Aruanã Joaquim Matheus Costa Rodrigues Pinheiro; Aleff Ricardo Santos Mendes; Milena Dara Farias de Jesus Neves; Carla Máximo Prado; Márcia Isabel Bittencourt-Mernak; Fernanda Paula Roncon Santana; João Henrique G Lago; Joicy Cortez de Sá; Claudia Quintino da Rocha; Eduardo Martins de Sousa; Valéria Costa Fontes; Marco Augusto Gregolin Grisoto; Angela Falcai; Lidio Gonçalves Lima-Neto Journal: Front Immunol Date: 2019-08-20 Impact factor: 7.561
Authors: Musaddique Hussain; Shahzada Khurram Syed; Mobeen Fatima; Saira Shaukat; Malik Saadullah; Ali M Alqahtani; Taha Alqahtani; Talha Bin Emran; Ali H Alamri; Muhammad Qasim Barkat; Ximei Wu Journal: J Inflamm Res Date: 2021-12-21
Authors: Jens Kamuf; Andreas Garcia Bardon; Alexander Ziebart; Robert Ruemmler; Johannes Schwab; Mobin Dib; Andreas Daiber; Serge C Thal; Erik K Hartmann Journal: BMC Anesthesiol Date: 2021-09-13 Impact factor: 2.217
Authors: Pierre Kory; Ginfranco Umberto Meduri; Jose Iglesias; Joseph Varon; Flavio Adsuara Cadegiani; Paul E Marik Journal: J Clin Med Res Date: 2022-02-24